Clinical Characteristics of Patients With Sleep Apnea in Korea
1 other identifier
observational
1,000
1 country
1
Brief Summary
Sleep-disordered breathing including obstructive sleep apnea (OSA) is an extremely common medical disorder associated with important morbidity. The purpose of this study is to understand the clinical features and course of patients with sleep apnea in Korea. Participants who are suspected of sleep apnea due to symptoms such as snoring, witnessed apneas, waking up with a choking sensation, excessive sleepiness, non-restorative sleep, difficulty initiating or maintaining sleep, fatigue or tiredness, and morning headache will be prospectively recruited at the outpatient clinic of Seoul National University Hospital. After polysomnography (PSG) or respiratory polygraphy, patients with sleep apnea including OSA and central sleep apnea (CSA) will be followed regularly. Participants not having sleep apnea (apnea-hypopnea index \< 5/hour) will only have a baseline visit. For only participants with the informed consent of donating blood, their blood samples will be collected and stored in the Seoul National University Hospital-Human Biobank (SNUH-HUB).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2019
CompletedFirst Submitted
Initial submission to the registry
November 27, 2019
CompletedFirst Posted
Study publicly available on registry
December 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2045
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2046
April 24, 2026
April 1, 2026
26.1 years
November 27, 2019
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The number of participants with adherence to positive airway pressure (PAP) therapy
PAP adherence is defined as the use of PAP therapy for ≥4 h/night on ≥70% of nights
Median follow up of 2 years
Secondary Outcomes (2)
The number of deaths
Median follow up of 15 years
The cause of death
Median follow up of 15 years
Other Outcomes (1)
Change of FEV1 and FVC in patients with OSA
Median follow up of 5 years
Study Arms (3)
obstructive sleep apnea (OSA)
5 or more predominantly obstructive respiratory events \[obstructive and mixed apneas, hypopneas or respiratory effort-related arousals (RERAs)\] per hour of sleep during a PSG or per hour of monitoring (respiratory polygraphy)
central sleep apnea (CSA)
PSG shows all of the following: 1. 5 or more central apneas and/or central hypopneas per hour of sleep. 2. The number of central and/or central hypopneas is \> 50% of the total number of apneas and hypopneas.
control
apnea-hypopnea index \< 5 per hour of sleep during a PSG or per hour of monitoring (respiratory polygraphy)
Eligibility Criteria
Participants who are suspected of sleep apnea due to symptoms such as snoring, witnessed apneas, waking up with a choking sensation, excessive sleepiness, non-restorative sleep, difficulty initiating or maintaining sleep, fatigue or tiredness, and morning headache will be prospectively recruited at the outpatient clinic of Seoul National University Hospital.
You may qualify if:
- Participants who are suspected of sleep apnea due to symptoms such as snoring, witnessed apneas, waking up with a choking sensation, excessive sleepiness, non-restorative sleep, difficulty initiating or maintaining sleep, fatigue or tiredness, and morning headache
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 03080, South Korea
Biospecimen
For only participants with the informed consent of donating blood, their blood samples (serum, plasma, and buffy coat) will be collected and stored in the Seoul National University Hospital-Human Biobank (SNUH-HUB).
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jaeyoung Cho, M.D.
Seoul National University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 27, 2019
First Posted
December 4, 2019
Study Start
November 11, 2019
Primary Completion (Estimated)
December 1, 2045
Study Completion (Estimated)
December 1, 2046
Last Updated
April 24, 2026
Record last verified: 2026-04